# Effect of Empagliflozin on Body Composition and Ketones

> **NCT03877406** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Diabetes Mellitus
- Fat; Intolerance, Pancreas

## Interventions

- **DRUG:** Empagliflozin 10 MG
- **DRUG:** Hypoglycemics Oral

## Key facts

- **NCT ID:** NCT03877406
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877406, "Effect of Empagliflozin on Body Composition and Ketones". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03877406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*